Design, Synthesis, and Biological Evaluation of Pyrimidine Dihydroquinoxalinone Derivatives as Tubulin Colchicine Site-Binding Agents That Displayed Potent Anticancer Activity Both In Vitro and In Vivo.

[1]  Duane D. Miller,et al.  Molecular interactions at the colchicine binding site in tubulin: an X-ray crystallography perspective. , 2021, Drug discovery today.

[2]  Duane D. Miller,et al.  X-ray Crystallography-Guided Design, Antitumor Efficacy, and QSAR Analysis of Metabolically Stable Cyclopenta-Pyrimidinyl Dihydroquinoxalinone as a Potent Tubulin Polymerization Inhibitor. , 2021, Journal of medicinal chemistry.

[3]  Duane D. Miller,et al.  Design, Synthesis, and Biological Evaluation of Stable Colchicine-Binding Site Tubulin Inhibitors 6-Aryl-2-benzoyl-pyridines as Potential Anticancer Agents. , 2021, Journal of medicinal chemistry.

[4]  Duane D. Miller,et al.  X-Ray Crystal Structure Guided Discovery and Antitumor Efficacy of Dihydroquinoxalinone as Potent Tubulin Polymerization Inhibitors. , 2019, ACS chemical biology.

[5]  Yong Li,et al.  The Natural Compound Withaferin A Covalently Binds to Cys239 of β-Tubulin to Promote Tubulin Degradation , 2019, Molecular Pharmacology.

[6]  Duane D. Miller,et al.  Heterocyclic-Fused Pyrimidines as Novel Tubulin Polymerization Inhibitors Targeting the Colchicine Binding Site: Structural Basis and Antitumor Efficacy. , 2018, Journal of medicinal chemistry.

[7]  K. Lee,et al.  In Vivo and Mechanistic Studies on Antitumor Lead 7-Methoxy-4-(2-methylquinazolin-4-yl)-3,4-dihydroquinoxalin-2(1H)-one and Its Modification as a Novel Class of Tubulin-Binding Tumor-Vascular Disrupting Agents. , 2017, Journal of medicinal chemistry.

[8]  B. Gigant,et al.  Mechanism of microtubule stabilization by taccalonolide AJ , 2017, Nature Communications.

[9]  Jie Wu,et al.  I2-Mediated Intramolecular C-H Amidation for the Synthesis of N-Substituted Benzimidazoles. , 2017, The Journal of organic chemistry.

[10]  S. Liekens,et al.  Blocking Blood Flow to Solid Tumors by Destabilizing Tubulin: An Approach to Targeting Tumor Growth. , 2016, Journal of medicinal chemistry.

[11]  A. Jimeno,et al.  Phase 1 Study of ABT‐751 in Combination With CAPIRI (Capecitabine and Irinotecan) and Bevacizumab in Patients With Advanced Colorectal Cancer , 2016, Journal of clinical pharmacology.

[12]  M. Steinmetz,et al.  Control of microtubule organization and dynamics: two ends in the limelight , 2015, Nature Reviews Molecular Cell Biology.

[13]  Duane D. Miller,et al.  Systemic delivery of nanoparticle formulation of novel tubulin inhibitor for treating metastatic melanoma , 2015, Drug Delivery and Translational Research.

[14]  Zhaopeng Liu,et al.  Tubulin colchicine binding site inhibitors as vascular disrupting agents in clinical developments. , 2015, Current medicinal chemistry.

[15]  Smriti Khanna,et al.  Cyclopentyl-pyrimidine based analogues as novel and potent IGF-1R inhibitor. , 2015, European journal of medicinal chemistry.

[16]  R. Paulsen,et al.  Synthesis and biological evaluations of new analogs of 2-methoxyestradiol: inhibitors of tubulin and angiogenesis. , 2014, European journal of medicinal chemistry.

[17]  Duane D. Miller,et al.  Design, Synthesis, and Biological Evaluation of Stable Colchicine Binding Site Tubulin Inhibitors as Potential Anticancer Agents , 2014, Journal of medicinal chemistry.

[18]  R. Ficner,et al.  Effects of the Tumor‐Vasculature‐Disrupting Agent Verubulin and Two Heteroaryl Analogues on Cancer Cells, Endothelial Cells, and Blood Vessels , 2014, ChemMedChem.

[19]  M. Ihnat,et al.  Discovery of antitubulin agents with antiangiogenic activity as single entities with multitarget chemotherapy potential. , 2014, ACS medicinal chemistry letters.

[20]  Keduo Qian,et al.  Optimization of 4-(N-Cycloamino)phenylquinazolines as a Novel Class of Tubulin-Polymerization Inhibitors Targeting the Colchicine Site , 2014, Journal of medicinal chemistry.

[21]  Laurence Lafanechère,et al.  Azaindole derivatives are inhibitors of microtubule dynamics, with anti‐cancer and anti‐angiogenic activities , 2013, British journal of pharmacology.

[22]  M. Steinmetz,et al.  Molecular Mechanism of Action of Microtubule-Stabilizing Anticancer Agents , 2013, Science.

[23]  Duane D. Miller,et al.  Formulation and Characterization of Polyester/Polycarbonate Nanoparticles for Delivery of a Novel Microtubule Destabilizing Agent , 2012, Pharmaceutical Research.

[24]  Marcel Knossow,et al.  The determinants that govern microtubule assembly from the atomic structure of GTP-tubulin. , 2011, Journal of molecular biology.

[25]  C. Dumontet,et al.  Microtubule-binding agents: a dynamic field of cancer therapeutics , 2010, Nature Reviews Drug Discovery.

[26]  S. Remick,et al.  Combretastatin A4 phosphate: a novel vascular disrupting agent. , 2010, Future oncology.

[27]  R. C.-Gaudreault,et al.  Quick and Simple Detection Technique to Assess the Binding of Antimicrotubule Agents to the Colchicine-Binding Site , 2010, Biological Procedures Online.

[28]  B. Potter,et al.  Class III β-tubulin expression and in vitro resistance to microtubule targeting agents , 2009, British Journal of Cancer.

[29]  D. Chaplin,et al.  A review and update of the current status of the vasculature-disabling agent combretastatin-A4 phosphate (CA4P) , 2009, Expert opinion on investigational drugs.

[30]  Chryso Kanthou,et al.  Disrupting tumour blood vessels , 2005, Nature Reviews Cancer.

[31]  J. Snyder,et al.  Quantitative structure-activity relationship (5D-QSAR) study of combretastatin-like analogues as inhibitors of tubulin assembly. , 2005, Journal of medicinal chemistry.

[32]  M. Jordan,et al.  Microtubules as a target for anticancer drugs , 2004, Nature Reviews Cancer.

[33]  I. Barasoain,et al.  The interaction of baccatin III with the taxol binding site of microtubules determined by a homogeneous assay with fluorescent taxoid. , 2001, Biochemistry.

[34]  H. Rosenkranz,et al.  Computational and molecular modeling evaluation of the structural basis for tubulin polymerization inhibition by colchicine site agents. , 1996, Bioorganic & medicinal chemistry.

[35]  J. Wolff,et al.  Localization of the Vinblastine-binding Site on β-Tubulin* , 1996, The Journal of Biological Chemistry.